The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Metabolomic Profile Associated With Insulin Resistance and Conversion to Diabetes in the Insulin Resistance Atherosclerosis Study
Open accessAbstract
CONTEXT: Metabolomic profiling of amino acids and acylcarnitines has revealed consistent patterns associated with metabolic disease. OBJECTIVE: This study used metabolomic profiling to identify analytes associated with insulin sensitivity (SI) and conversion to type 2 diabetes (T2D). DESIGN: A multiethnic cohort from the Insulin Resistance Atherosclerosis Study. SETTING: Community-based. PATIENTS: A total of 196 subjects (European American, Hispanic, and African American) were selected to represent extremes of the SI distribution and conversion to T2D between baseline and followup exams. MAIN OUTCOME: Mass spectrometry-based profiling of 69 metabolites. Subjects participated in a frequently sampled i.v. glucose tolerance test to measure SI and acute insulin response. T2D status was determined by a 2-hour oral glucose tolerance test. RESULTS: Logistic regression analysis from 72 high and 75 low SI subjects revealed significantly decreased glycine and increased valine, leucine, phenylalanine, and combined glutamine and glutamate (P = .0079-7.7 × 10(-6)) in insulin-resistant subjects. Ethnic-stratified results were strongest in European Americans. Comparing amino acid profiles between subjects that converted to T2D (76 converters; 70 nonconverters) yielded a similar pattern of associations: decreased glycine and increased valine, leucine, and combined glutamine and glutamate (P = .016-.00010). Importantly, β-cell function as a covariate revealed a similar pattern of association. CONCLUSIONS: A distinct pattern of differences in amino acids were observed when comparing subjects with high and low levels of SI. This pattern was associated with conversion to T2D, remaining significant when accounting for β-cell function, emphasizing a link between this metabolic profile and insulin resistance. These results demonstrate a consistent metabolic signature associated with insulin resistance and conversion to T2D, providing potential insight into underlying mechanisms of disease pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
Self-citationMetabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143 · cited 2×
“Recent metabolic profiling of serum or plasma amino acids and acylcarnitines has revealed a strikingly consistent pattern, especially of amino acid profiles, associated with multiple presentations of metabolic disease including obesity (3), coronary artery disease (CAD) (4, 5), active vs sedentary lifestyle (6), and m…”
BackgroundResultAssessment of Insulin Sensitivity in Vivo*
Bergman, R. N., Finegood, D. T., & Ader, M. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,066
Self-citationGenomics, type 2 diabetes, and obesity
McCarthy, M. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0906948 · Cited by 938
Pacini, G., & Bergman, R. N. (1986) · Computer Methods and Programs in Biomedicine · doi:10.1016/0169-2607(86)90106-9 · Cited by 695
Self-citationMetabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans
Cheng, S., Rhee, E. P., Larson, M. G., Lewis, G. D., McCabe, E. L., Shen, D., Palma, M. J., Roberts, L. D., Dejam, A., Souza, A. L., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.067827 · Cited by 587
The Insulin Resistance Atherosclerosis Study (IRAS)
Wagenknecht, L. E., Mayer, E. J., Rewers, M., Haffner, S., Selby, J., Borok, G. M., Henkin, L., Howard, G., Savage, P. J., Saad, M. F., et al. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(95)00062-3 · Cited by 492
Self-citationTai, E. S., Tan, M. L. S., Stevens, R. D., Low, Y. L., Muehlbauer, M. J., Goh, D. L. M., Ilkayeva, O. R., Wenner, B. R., Bain, J. R., Lee, J. J. M., et al. (2010) · Diabetologia · doi:10.1007/s00125-009-1637-8 · Cited by 471
Self-citationShah, S. H., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Crosslin, D. R., Haynes, C., Dungan, J., Newby, L. K., Hauser, E. R., Ginsburg, G. S., et al. (2010) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.109.852814 · Cited by 465
Self-citationAn, J., Muoio, D. M., Shiota, M., Fujimoto, Y., Cline, G. W., Shulman, G. I., Koves, T. R., Stevens, R., Millington, D., & Newgard, C. B. (2004) · Nature Medicine · doi:10.1038/nm995 · Cited by 450
Self-citation
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Emerging applications of metabolomics in drug discovery and precision medicine
Wishart, D. S. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.32 · Cited by 1,488
Metabolomics for Investigating Physiological and Pathophysiological Processes
Wishart, D. S. (2019) · Physiological Reviews · doi:10.1152/physrev.00035.2018 · Cited by 1,212
Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis
Guasch-Ferré, M., Hruby, A., Toledo, E., Clish, C. B., Martínez-González, M. A., Salas-Salvadó, J., & Hu, F. B. (2016) · Diabetes Care · doi:10.2337/dc15-2251 · Cited by 905
Metabolomics and Metabolic Diseases: Where Do We Stand?
Newgard, C. B. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.018 · Cited by 750
Self-citationAltered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance
Gaggini, M., Carli, F., Rosso, C., Buzzigoli, E., Marietti, M., Della Latta, V., Ciociaro, D., Abate, M. L., Gambino, R., Cassader, M., et al. (2018) · Hepatology · doi:10.1002/hep.29465 · Cited by 465
Lotta, L. A., Scott, R. A., Sharp, S. J., Burgess, S., Luan, J., Tillin, T., Schmidt, A. F., Imamura, F., Stewart, I. D., Perry, J. R. B., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002179 · Cited by 417
Inflammation, vitamin B6 and related pathways
Ueland, P. M., McCann, A., Midttun, Ø., & Ulvik, A. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.08.001 · Cited by 382
White, P. J., McGarrah, R. W., Grimsrud, P. A., Tso, S.-C., Yang, W.-H., Haldeman, J. M., Grenier-Larouche, T., An, J., Lapworth, A. L., Astapova, I., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.015 · Cited by 365
“BCAA and their metabolites are also prognostic at baseline for incident type 2 diabetes (T2D) and obesity intervention outcomes (Palmer et al., 2015; Shah et al., 2012; Wang et al., 2011).”
Self-citationGlycine Metabolism and Its Alterations in Obesity and Metabolic Diseases
Alves, A., Bassot, A., Bulteau, A.-L., Pirola, L., & Morio, B. (2019) · Nutrients · doi:10.3390/nu11061356 · Cited by 365
Morze, J., Wittenbecher, C., Schwingshackl, L., Danielewicz, A., Rynkiewicz, A., Hu, F. B., & Guasch-Ferré, M. (2022) · Diabetes Care · doi:10.2337/dc21-1705 · Cited by 298
Vanweert, F., Schrauwen, P., & Phielix, E. (2022) · Nutrition & Diabetes · doi:10.1038/s41387-022-00213-3 · Cited by 289
Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street
White, P. J., McGarrah, R. W., Herman, M. A., Bain, J. R., Shah, S. H., & Newgard, C. B. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101261 · Cited by 287
Self-citationMetabolomics in Diabetes and Diabetic Complications: Insights from Epidemiological Studies
Jin, Q., & Ma, R. C. W. (2021) · Cells · doi:10.3390/cells10112832 · Cited by 252
Yan-Do, R., Duong, E., Manning Fox, J. E., Dai, X., Suzuki, K., Khan, S., Bautista, A., Ferdaoussi, M., Lyon, J., Wu, X., et al. (2016) · Diabetes · doi:10.2337/db15-1272 · Cited by 82
Metadata
- Authors
- Palmer, N. D., Stevens, R. D., Antinozzi, P. A., Anderson, A., Bergman, R. N., Wagenknecht, L. E., Newgard, C. B., & Bowden, D. W.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-03-01
- Volume
- 100
- Issue
- 3
- Pages
- E463-E468
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1989326472
- Cited by
- 253
- References
- 20
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.